| Title: | The role of regulatory T cells and their therapeutic potential in hypertensive disease of pregnancy : a literature review |
|---|
| Authors: | ID Headen, Kyle (Author)
ID Jakaite, Vaidile (Author)
ID Mesarič, Vita Andreja (Author)
ID Scotta, Cristiano (Author)
ID Lombardi, Giovanna (Author)
ID Nicolaides, Kypros H. (Author)
ID Shangaris, Panicos (Author) |
|---|
| Files: |  PDF - Presentation file, download (1,10 MB)
MD5: 20ABB16180BACBC9FD92484A1436D4A8
 URL - Source URL, visit https://www.mdpi.com/1422-0067/25/9/4884
|
|---|
| Language: | English |
|---|
| Typology: | 1.02 - Review Article |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Abstract: Hypertensive disorders of pregnancy (HDP), including preeclampsia (PE) and gestational hypertension (GH), are major causes of maternal and foetal morbidity and mortality. This review elucidates the role of regulatory T cells (Tregs) in the immunological aspects of HDP and explores their therapeutic potential. Tregs, which play a critical role in maintaining immune homeostasis, are crucial in pregnancy to prevent immune-mediated rejection of the foetus. The review highlights that Tregs contribute to immunological adaptation in normal pregnancy, ensuring foetal acceptance. In contrast, HDP is associated with Treg dysfunction, which is marked by decreased numbers and impaired regulatory capacity, leading to inadequate immune tolerance and abnormal placental development. This dysfunction is particularly evident in PE, inwhich Tregs fail to adequatelymodulate the maternal immune response against foetal antigens, contributing to the pathophysiology of the disorder. Therapeutic interventions aiming to modulate Treg activity represent a promising avenue for HDP management. Studies in animal models and limited clinical trials suggest that enhancing Treg functionality could mitigate HDP symptoms and improve pregnancy outcomes. However, given the multifactorial nature of HDP and the intricate regulatory mechanisms of Tregs, the review explores the complexities of translating in vitro and animal model findings into effective clinical therapies. In conclusion, while the precise role of Tregs in HDP is still being unravelled, their central role in immune regulation during pregnancy is indisputable. Further research is needed to fully understand the mechanisms by which Tregs contribute to HDP and to develop targeted therapies that can safely and effectively harness their regulatory potential for treating hypertensive diseases of pregnancy. |
|---|
| Keywords: | Tregs, preeclampsia, hypertensive disorders, immune tolerance, semi-allogeneic foetus |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2024 |
|---|
| Number of pages: | str. 1-14 |
|---|
| Numbering: | Vol. 25, iss. 9 [article no.] 4884 |
|---|
| PID: | 20.500.12556/DiRROS-25018  |
|---|
| UDC: | 618.2/.7 |
|---|
| ISSN on article: | 1422-0067 |
|---|
| DOI: | 10.3390/ijms25094884 |
|---|
| COBISS.SI-ID: | 259595267 |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis vira z dne 2. 12. 2025;
|
|---|
| Publication date in DiRROS: | 07.01.2026 |
|---|
| Views: | 305 |
|---|
| Downloads: | 164 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
